Association of low interleukin-10 levels with the metabolic syndrome in obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1055-1058

  Esposito, Katherine ^a   Pontillo, Alessandro ^a   Giugliano, Francesco ^a   Giugliano, Giovanni ^a   Marfella, Raffaele ^a   Nicoletti, Gianfranco ^a   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHESIS; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-10; OBESITY;

EID: 0037342025     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021437     Document Type: Article

References (24)

1. Eckel RH, Krauss RM 1998 American Heart Association call to action: obesity as a major risk factor for coronary heart disease: AHA Nutrition Committee. Circulation 97:2099-2100
2. Grundy SM 2002 Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105:2696-2698
3. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
4. Lebovitz HE 2001 Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109(Suppl 2):S135-S148
5. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC 1997 Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273-277
6. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D 2002 Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809
7. Tedgui A, Mallat Z 2001 Anti-inflammatory mechanisms in the vascular wall. Circ Res 88:877-887
8. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI 1999 Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 19:2847-2853
9. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, Sato N, Arakawa N, Suzuki T, Aoki A, Suzuki T, Hiramori K 1997 Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 17:145-150
10. NCEP 2001 Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486-2497
11. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults. JAMA 287:356-359
12. Tracy RP 2001 Is visceral fat the "enemy within?" Arterioscler Thromb Vasc Biol 21:881-883
13. Gabay C, Kushner I 1999 Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
14. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V 2000 Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214
15. Heinrich PC, Castell JV, Andus T 1990 Interleukin-6 and the acute phase response. Biochem J 265:1591-1601
16. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Human subcutaneous adipose tissue releases IL-6 but not TNF-α in vivo. J Clin Endocrinol Metab 82:4196-4200
17. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET 2002 Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564-569
18. Bastard J-P, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B 2000 Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338-3342
19. Wetsendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DJ, Vandenbroucke JP 1997 Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173
20. Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A 1999 Expression of interleukin-10 in advanced human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19:611-616
21. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC 2001 Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:746-749
22. van Exel E, Gussekloo J, de Craen AJM, Bootsma-van der Wiel A, Frölich M, Westendorp RGJ 2002 Inflammation and stroke. The Leiden 85-plus study. Stroke 33:1135-1138
23. van Exel E, Gussekloo J, de Craen AJM, Frölich M, Bootsma-van der Wiel A, Westendorp RGJ 2002 Low production capacity of interelukin-10 associates with the metabolic syndrome and type 2 diabetes. The Leiden 85-plus study. Diabetes 51:1088-1092
24. Gunnett CA, Heistad DD, Faraci FM 2002 Interleukin-10 protects nitric oxide-dependent relaxation during diabetes. Diabetes 51:1931-1937